Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Clinical trial NCT06241781 · RECRUITING
Trial details
- NCT number
- NCT06241781
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2027-01-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.